Operating
Other Non-Cash Income and Expense
Moderna Other Non-Cash Income and Expense increased by 77.8% to -$6.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 200.0%, from -$2.00M to -$6.00M.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2020
Last reportedQ1 2026May 1, 2026
Metric ID:
pg_other_noncash_income_expenseHistorical Data
17 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | -$15.00M | -$21.00M | $4.00M | $8.00M | -$37.00M | -$3.00M | -$4.00M | $0.00 | -$54.00M | -$2.00M | -$34.00M | -$14.00M | -$27.00M | -$6.00M |
| QoQ Change | — | — | — | — | -40.0% | +119.0% | +100.0% | -562.5% | +91.9% | -33.3% | +100.0% | — | +96.3% | <-999% | +58.8% | -92.9% | +77.8% |
| YoY Change | — | — | — | — | — | — | +153.3% | -76.2% | -175.0% | -150.0% | +100.0% | — | +33.3% | -750.0% | — | +50.0% | -200.0% |
Range-$54.00M – $8.00M
Avg YoY Growth-112.7%
Median YoY Growth-76.2%
Other Non-Cash Income and Expense at Other Companies
Frequently Asked Questions
- What is Moderna's other non-cash income and expense?
- Moderna (MRNA) reported other non-cash income and expense of -$6.00M in Q1 2026.
- How has Moderna's other non-cash income and expense changed year-over-year?
- Moderna's other non-cash income and expense decreased by 200.0% year-over-year, from -$2.00M to -$6.00M.